from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2753c/dapA

LFCtreatmentdescriptionclass of inhibitor

-2.049

Amikacinug/mL Amikacintranslation

-1.637

Cap5-10ug/mL Capreomycintranslation

-1.381

Rox10-50 ug/mL Roxithromycintranslation

0.044

SM2-5 ug/mL Streptomycintranslation

-3.367

Tet5-10 ug/mL Tetracyclinetranslation

-0.274

Rif0.2-5ug/mL Rifampicintranscription

-0.620

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.242

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.499

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.768

CPZ10-50 ug/mL Chlorpromazinerespiration

1.330

Clofazimine10-13 ug/mL Clofaziminerespiration

0.451

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.129

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.966

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.118

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.523

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.025

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.812

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.827

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.139

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.811

KCN5-20 ug/mL Potassium cyaniderespiration

0.760

NaN30.2-2 mM Sodium aziderespiration

0.096

Nigericin50 uM Nigericinrespiration

0.721

TRC10-150 ug/mL Triclosanrespiration

0.603

TRZ10-25 ug/mL Thioridazinerespiration

-2.475

Valinomycin0.5-10 uM Valinomycinrespiration

-0.100

ZnSO42 mM ZnSO4respiration

-0.344

menadione6-10 ug/mL Menadionerespiration

0.113

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.417

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.797

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.651

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.388

NRP_1Non-replicating persistence stage 1dosRassociated

0.167

Amp0.2mg/mL AmpicillincellWall

-0.049

Cephalexin20-100 ug/mL CephalexincellWall

-0.224

Cerulenin0.32-5 ug/mL CerulenincellWall

0.077

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.077

EMB10-20 ug/mL EthambutolcellWall

0.835

Eta12-40 ug/mL EthionamidecellWall

1.116

INH0.2-0.4 ug/mL IsoniazidcellWall

0.805

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.114

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.426

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.174

BZA0.12 mg/mL BenzamidearomaticAmides

0.565

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.294

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.164

H2O24 mM hydrogen peroxideDNAdamaging

-0.254

Levo10 ug/mL LevofloxacinDNAdamaging

-0.737

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.718

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.170

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.575

UVUV-irradiationDNAdamaging

-0.116

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.654

Antimycin12.5-50 ug/mL Antimycin A?

-0.450

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.185

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.112

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.465

PA8240.2-2 ug/mL PA-824?

1.238

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.267

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.227

Verapamil50 uM Verapamil?

-0.512

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.268

methoxatin10-20 ug/mL Methoxatin?